Your browser doesn't support javascript.
Imaging Enterobacterales infections in patients using pathogen-specific positron emission tomography.
Ordonez, Alvaro A; Wintaco, Luz M; Mota, Filipa; Restrepo, Andres F; Ruiz-Bedoya, Camilo A; Reyes, Carlos F; Uribe, Luis G; Abhishek, Sudhanshu; D'Alessio, Franco R; Holt, Daniel P; Dannals, Robert F; Rowe, Steven P; Castillo, Victor R; Pomper, Martin G; Granados, Ulises; Jain, Sanjay K.
  • Ordonez AA; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Wintaco LM; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Mota F; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Restrepo AF; Department of Nuclear Medicine, Hospital Internacional de Colombia, Fundación Cardiovascular de Colombia, Piedecuesta 681017, Colombia.
  • Ruiz-Bedoya CA; Biomedical and Biological Sciences Graduate Program, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá 111711, Colombia.
  • Reyes CF; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Uribe LG; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Abhishek S; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • D'Alessio FR; Department of Internal Medicine, Hospital Internacional de Colombia, Fundación Cardiovascular de Colombia, Piedecuesta 681017, Colombia.
  • Holt DP; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Dannals RF; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Rowe SP; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Castillo VR; Department of Critical Care, Hospital Internacional de Colombia, Fundación Cardiovascular de Colombia, Piedecuesta 681017, Colombia.
  • Pomper MG; Department of Infectious Diseases, Hospital Internacional de Colombia, Fundación Cardiovascular de Colombia, Piedecuesta 681017, Colombia.
  • Granados U; Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Jain SK; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Sci Transl Med ; 13(589)2021 04 14.
Article in English | MEDLINE | ID: covidwho-1186204
ABSTRACT
Enterobacterales represent the largest group of bacterial pathogens in humans and are responsible for severe, deep-seated infections, often resulting in sepsis or death. They are also a prominent cause of multidrug-resistant (MDR) infections, and some species are recognized as biothreat pathogens. Tools for noninvasive, whole-body analysis that can localize a pathogen with specificity are needed, but no such technology currently exists. We previously demonstrated that positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-d-sorbitol (18F-FDS) can selectively detect Enterobacterales infections in murine models. Here, we demonstrate that uptake of 18F-FDS by bacteria occurs via a metabolically conserved sorbitol-specific pathway with rapid in vitro 18F-FDS uptake noted in clinical strains, including MDR isolates. Whole-body 18F-FDS PET/computerized tomography (CT) in 26 prospectively enrolled patients with either microbiologically confirmed Enterobacterales infection or other pathologies demonstrated that 18F-FDS PET/CT was safe, could rapidly detect and localize Enterobacterales infections due to drug-susceptible or MDR strains, and differentiated them from sterile inflammation or cancerous lesions. Repeat imaging in the same patients monitored antibiotic efficacy with decreases in PET signal correlating with clinical improvement. To facilitate the use of 18F-FDS, we developed a self-contained, solid-phase cartridge to rapidly (<10 min) formulate ready-to-use 18F-FDS from commercially available 2-deoxy-2-[18F]fluoro-d-glucose (18F-FDG) at room temperature. In a hamster model, 18F-FDS PET/CT also differentiated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia from secondary Klebsiella pneumoniae pneumonia-a leading cause of complications in hospitalized patients with COVID-19. These data support 18F-FDS as an innovative and readily available, pathogen-specific PET technology with clinical applications.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Enterobacteriaceae Infections / Positron Emission Tomography Computed Tomography Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Scitranslmed.abe9805

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Enterobacteriaceae Infections / Positron Emission Tomography Computed Tomography Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Scitranslmed.abe9805